Multinational pharmaceutical giant Aspen Pharmacare is prepared to further streamline its global operations. While the company has not officially hoisted a “for sale” sign, leadership has indicated it remains open to further Aspen Pharmacare asset disposals if the price is right. This strategic openness follows the landmark sale of its Asia-Pacific (APAC) division. The R26.5 billion transaction serves as a…
Tag: Stock Market
-
Lilly Hits $1 Trillion Valuation with Weight-Loss Success
In a historic milestone for the pharmaceutical industry, Eli Lilly surged to a market value of $1 trillion on Friday. It became the first drugmaker to join an exclusive club previously dominated by technology heavyweights. This event marked the moment Lilly hit a $1 trillion valuation. It highlighted the company’s rapid ascent as a global powerhouse in the weight-loss sector.…
-
Life Healthcare Share Price Stumbles Following R2.9bn Liability Adjustment
The Life Healthcare share price took a significant knock in early trade yesterday, falling by as much as 9%. This happened after the hospital group released a trading statement detailing a multi-billion Rand adjustment to its financial liabilities. Investors reacted sharply to news that an R2.9bn adjustment related to the “Piramal liability” had heavily impacted profit from continuing operations. This…
-
AfroCentric’s JSE Collapse Fuels a New Healthcare Empire
As insurance giant Sanlam tightens its grip on health-fin services specialist AfroCentric, the line between public company and private control has all but vanished. What remains is a powerful lesson in strategic patience. It reveals how corporations (or businesses) can methodically turn market neglect into a corporate opportunity. While AfroCentric still technically trades on the JSE, its story is no…